Evolution has ability to pay 16c to purchase 7.5 million HT8 shares, so if the SP is lower than 16c, they will not touch this, but if the SP goes to say 20c, then Evolution will pay HT8 $1.2million to exercise the options - meaning that the guys expect the share price to go well over 16c. I guess this is a good problem to have. All long term shareholders should remember that it was on a couple of cents for a long time.
- Forums
- ASX - By Stock
- HT8
- Ann: Capital Raising to Fund Growth
Ann: Capital Raising to Fund Growth, page-21
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HT8 (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.991M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 467179 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 13532 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 467179 | 0.011 |
1 | 109090 | 0.010 |
3 | 390000 | 0.009 |
2 | 535000 | 0.008 |
2 | 230000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 13532 | 3 |
0.013 | 1272868 | 5 |
0.014 | 250000 | 1 |
0.015 | 1105000 | 5 |
0.016 | 28000 | 1 |
Last trade - 16.12pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
HT8 (ASX) Chart |
Day chart unavailable